WASHINGTON — Eli Lilly & Co. won approval Thursday to sell the antidepressant Cymbalta, its second-biggest drug, as a treatment for pain. The Food and Drug Administration cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back …
Continue reading here:
Lilly gains FDA approval to sell Cymbalta – Indianapolis Star
